Doug Cole
Managing Partner at Flagship Pioneering
Cambridge, Massachusetts
Writes $500K – $15M checks · typically $1.5M
About
Douglas Cole, a former clinician-turned-investor, has spent over two decades conceiving and chairing platform biotech companies (Sigilon, Repertoire, Foghorn) focused on chromatin regulation, immune repertoire mapping and encapsulated cell therapies.
Invests in
AgTechAI & Machine LearningBiotechClimate TechFoodTechHealthtech
Colleagues at Flagship Pioneering
Avak Kahvejian
General Partner at Flagship Pioneering
David Berry
General Partner at Flagship Pioneering
Geoffrey von Maltzahn
General Partner at Flagship Pioneering
Ignacio Martinez
General Partner at Flagship Pioneering
Nicholas Plugis
Senior Principal at Flagship Pioneering
Noubar Afeyan
Investor at Flagship Pioneering
Stephane Bancel
Partner at Flagship Pioneering
Stephen Berenson
Managing Partner Emeritus at Flagship Pioneering
Network1
Investors connected to Doug in public investor directories — a warm-intro map.